Why the study?
Does ketorolac or indomethacin improve postoperative analgesia in women undergoing day-case laparoscopic surgery?
Does ketorolac or indomethacin improve postoperative analgesia in women undergoing day-case laparoscopic surgery?
Ketorolac 30 mg IM provides significant postoperative analgesia compared to placebo in women undergoing day-case laparoscopic surgery, though safety concerns regarding renal failure warrant caution.
Ketorolac 30 mg IM reduces early postoperative pain after day-case laparoscopy; supports short-term NSAID analgesia while renal safety needs confirmation in larger trials.
The analgesia provided in the postoperative period by three regimens commonly used in our private anaesthetic practice were compared in a double-blind study of one hundred and thirty-seven women presenting for day-case laparoscopic procedures. After random allocation into three groups, all patients were similarly anaesthetized and then received both a rectal suppository and an IM injection. Group P received two placebos, Group I had an indomethacin suppository 100 mg and Group K an IM injection of ketorolac 30 mg. The trial showed a statistically significant reduction in pain at 180 minutes postoperatively in the group receiving ketorolac (visual analog pain score of 13.8 v 21.7). The parenterally administered ketorolac may be a useful analgesic supplement in these patients. However the trial was aborted following the appearance in the literature of case reports of postoperative renal failure. Further investigation of the efficacy and side-effect profile of reduced doses may be warranted.
No takes yet. Share an insight, caveat, or question.
Murrell et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: